73 results on '"CIANCIOLO, GIUSEPPE"'
Search Results
2. Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes
3. Future treatment of vascular calcification in chronic kidney disease
4. #5440 BONE TURNOVER MARKERS AND BONE MINERAL DENSITY 1 YEAR AFTER KIDNEY TRANSPLANTATION
5. Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease
6. Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population
7. Restenosis in Hemodialytic Fistulas and Chronic Kidney Disease-Associated Vascular Disease: Two Pathologies Driven by Metakaryotic Stem Cells
8. Fibroblast Growth Factor 23: Mineral Metabolism and Beyond
9. Vitamin D and the Kidney: Two Players, One Console
10. Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease
11. Erratum to: A roadmap to parathyroidectomy for kidney transplant candidates
12. A roadmap to parathyroidectomy for kidney transplant candidates
13. The Role of Vitamin K in CKD-MBD
14. Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation
15. The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study
16. Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross‐Sectional Study
17. Letter to the Editor: A comment to “dietary iron and vitamins in association with mortality”
18. MO798ORAL CALCITRIOL USE, VERTEBRAL FRACTURES AND VASCULAR CALCIFICATION IN HEMODIALYSIS PATIENTS: RESULTS FROM VITAMIN K ITALIAN (VIKI) STUDY
19. Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients
20. Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
21. Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients
22. Vitamin K and Osteoporosis
23. The role of activin: the other side of chronic kidney disease–mineral bone disorder?
24. SGLT2 inhibitors, sodium and off-target effects: an overview
25. Do SGLT-2 Inhibitors Act Only Through a Functional Tubuloglomerular Feedback Induced by the Increased Outflow of Sodium?
26. The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
27. Glifozines and cardiorenal outcomes
28. Current Therapy in CKD Patients Can Affect Vitamin K Status
29. Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery
30. Nutritional vitamin D in CKD: Should we measure? Should we treat?
31. Time evolution of restless legs syndrome in haemodialysis patients
32. The Role of Vitamin K in Vascular Calcification
33. Mineral and Electrolyte Disorders With SGLT2i Therapy
34. New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
35. The Key Role of Phosphate on Vascular Calcification
36. Folic Acid and Vitamin B12 Administration in CKD, Why Not?
37. Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?
38. Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?
39. Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights
40. Tyrosine-Kinase Inhibitors for Treatment in Hemodialysis Patients on Kidney Transplant Waiting List. Comment on: Nakai et al.
41. The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: “Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer”. Molecules 2017, 22, 582, pii: E582
42. Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders
43. Vitamin D-FGF-23 axis in kidney transplant recipients
44. Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?
45. Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First
46. FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde
47. Vitamin D in patients with chronic kidney disease: a position statement of the Working Group “Trace Elements and Mineral Metabolism” of the Italian Society of Nephrology
48. Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
49. Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy
50. Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.